Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medistep HealthcareNSE:MEDISTEP +5.74%19 EV-to-FCF is -1.81 as of Jul. 19, 2026. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 72 Medical Distribution companies, Medistep Healthcare ranks worse than 1388887.5% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medistep Healthcare's Enterprise Value is ₹275.0 Mil.
Medistep Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was ₹-151.7 Mil. Therefore, Medistep Healthcare's EV-to-FCF for today is -1.81.
The historical rank and industry rank for Medistep Healthcare's EV-to-FCF or its related term are showing as below:
NSE:MEDISTEP'
s EV-to-FCF Range Over the Past 10 Years
Min: -1.81 Med: 1467.06 Max: 2669.32
Current: -1.81
During the past 4 years, the highest EV-to-FCF of Medistep Healthcare was 2669.32. The lowest was -1.81. And the median was 1467.06.
NSE:MEDISTEP's EV-to-FCF is ranked worse than 100% of 72
companies
in the Medical Distribution industry
Industry Median: 17.235
vs NSE:MEDISTEP: -1.81
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medistep Healthcare's PE Ratio (TTM) for today is calculated as:
Medistep Healthcare's share price for today is ₹19.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medistep Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was ₹4.338.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medistep Healthcare EV-to-FCF Related Terms
Medistep Healthcare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medistep Healthcare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MEDISTEP vs MCK, CAH, COR: EV-to-FCF Comparison
For the Medical Distribution subindustry, Medistep Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistep Healthcare EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medistep Healthcare's EV-to-FCF falls into.
Medistep Healthcare's current Enterprise Value is ₹275.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medistep Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was ₹-151.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistep Healthcare (NSE:MEDISTEP) has a EV-to-FCF of -1.81 as of Jul. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medistep Healthcare and its competitors. According to the industry distribution chart, Medistep Healthcare ranks #999999 out of 72 companies in the Medical Distribution industry.
Is Medistep Healthcare's EV-to-FCF too high?
Medistep Healthcare's current EV-to-FCF is -1.81. Based on the distribution chart, Medistep Healthcare ranks #999999 out of 72 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medistep Healthcare ranks #999999 out of 72 companies for EV-to-FCF. This places Medistep Healthcare in the lower half of its industry. The industry median EV-to-FCF is 17.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.24, based on 72 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medistep Healthcare and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current EV-to-FCF is -1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current EV-to-FCF of -1.81. The current EV-to-FCF is -1.81. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current EV-to-FCF is -1.81 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score
Get the complete analysis for NSE:MEDISTEP
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDISTEP has been successfully added to your 
